Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study

NCT02457286 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped patients do not want to participate

Conditions

Non-alcoholic Fatty Liver Disease (NAFLD)

Interventions

DRUG: Metformin
BEHAVIORAL: Lifestyle modifications
DEVICE: Fibroscan device (Echosens)

Sponsor

Northwell Health